medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

salud publica mex 2019; 61 (3)

Tobacco use and lung cancer

Zinser-Sierra JW
Full text How to cite this article

Language: Spanish
References: 34
Page: 303-307
PDF size: 268.55 Kb.


Key words:

lung cancer, smoking habit, nicotine, addiction, prevention.

ABSTRACT

Smoking is the main cause of lung cancer. It plays a role in the etiology, and depending on the intensity and duration, it also has an influence on histology, stage and therapeutic outcome. Therefore, it is never too late to stop smoking. Tobacco smoke is so toxic, that there is no safe smoking modality. Filters, light cigarettes, pipes, water pipes, etc. are prohibitively harmful. In addition, the electronic nicotine delivery systems, besides promoting addiction, cause acute respiratory and cardiovascular effects. In addition, even though long-term consequences are yet to be known, cell proliferation and tumor progression have been identified. Tobacco control efforts should look at all these new products as its main threat.


REFERENCES

  1. Morabia A. Quality, originality, and significance of the 1939 “Tobacco consumption and lung carcinoma” article by Mueller, including translation of a section of the paper. Prev Med. 2012;55(3):171-7. https://doi. org/10.1016/j.ypmed.2012.05.008

  2. Doll R, Hill B. Smoking and carcinoma of the lung. BMJ. 1950;2:739-48. https://doi.org/10.1136/bmj.2.4682.739

  3. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. A study of six hundred and eightyfour proved cases. JAMA. 1950;143(4):329-36. https://doi.org/10.1001/ jama.1950.02910390001001

  4. Bergen AW, Caporaso N. Cigarette smoking. JNCI. 1999;91(16):1365-75. https://doi.org/10.1093/jnci/91.16.1365

  5. Fisher RA. Dangers of Cigarette-smoking. Br Med J. 1957;2:43. https:// doi.org/10.1136/bmj.2.5035.43

  6. Editorial board. Cancer of the lung. Editorial. N Engl J Med. 1953;249(11):465-6. https://doi.org/10.1056/NEJM195309102491110

  7. Hecht SS. Tobacco smoke carcinogens and lung cancer. JNCI. 1999;91(14):1194-210. https://doi.org/10.1093/jnci/91.14.1194

  8. Wiencke JK, Thurston SE, Kelsey KT, Varkonyi A, Wain JC, Mark EJ, Christiani DC. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. JNCI. 1999;91(7):614-9. https://doi.org/10.1093/ jnci/91.7.614

  9. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728-36. https://doi.org/10.1056/NEJMoa1211776

  10. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638-41. https://doi.org/10.1038/ nature06846

  11. Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA. Comparison of aspects of smoking among the four histological subtypes of lung cancer. Tob Control. 2008;17:198-204. https://doi.org/10.1136/tc.2007.022582

  12. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med. 1997;26:427-34. https://doi.org/10.1006/pmed.1997.0183

  13. Swanton C, Govindan R. Clinical implications of genomic discoveries in lung cancer. N Engl J Med. 2016;374:1864-73. https://doi.org/10.1056/ NEJMra1504688

  14. Harris JE, Thurn MJ, Mondul AM, Calle EE. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8. BMJ. 2004;328:72. https://doi.org/10.1136/ bmj.37936.585382.44

  15. Tindle HA, Shiffman S, Hartman AM, Bost JE. Switching to ‘‘lighter’’ cigarettes and quitting smoking. Tob Control. 2009;18:485-90. https://doi. org/10.1136/tc.2008.029314

  16. Kobrinsky NL, Klug MG, Hokanson PJ, Sjolander DE, Burd L. Impact of smoking on cancer stage at diagnosis. J Clin Oncol. 2003;21(5):907-13 https://doi.org/10.1200/JCO.2003.05.110

  17. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited stage small cell lung cancer is associated with decreased survival. J Clin Oncol. 2003;21(8):1544-9. https://doi.org/10.1200/ JCO.2003.10.089

  18. Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease and cancer in men. N Engl J Med. 1999;340:1773-80. https://doi. org/10.1056/NEJM199906103402301

  19. Shihadeh A, Azar S, Antonios C, Haddad A. Towards a topographical model of narghile water-pipe café smoking: a pilot study in a high socioeconomic status neighborhood of Beirut, Lebanon. Pharmacol Biochem Behav. 2004;79(1):75-82. https://doi.org/10.1016/j.pbb.2004.06.005

  20. St Helen G, Benowitz NL, Dains KM, Havel C, Peng M, Jacob P 3 rd. Nicotine and carcinogen exposure after water pipe smoking in hookah bars. Cancer Epidemiol Biomarkers Prev. 2014;23:1055-66. https://doi. org/10.1158/1055-9965.EPI-13-0939

  21. Wang MP, Ho SY, Leung LT, Lam TH. Electronic cigarette use and respiratory symptoms in chinese adolescents in Hong Kong. JAMA Pediatr. 2016;170(1):89-91. https://doi.org/10.1001/jamapediatrics.2015.3024

  22. Martin E, Clapp PW, Rebuli ME, Pawlak EA, Glista-Baker E, Benowitz NL, et al. E-cigarette use results in suppression of immune and inflammatory- response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell and Mol Physiol. 2016;311(1):L135-44. https://doi. org/10.1152/ajplung.00170.2016

  23. Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nature Rev Cardiol. 2017;14(8):447-56. https://doi.org/10.1038/ nrcardio.2017.36

  24. Behar RZ, Wang Y, Talbot P. Comparing the cytotoxicity of electronic cigarette fluids, aerosols and solvents. Tob Control. 2018;27:325-33. https://doi.org/10.1136/tobaccocontrol-2016-053472

  25. Kosmider L, Sobczak A, Prokopowicz A, Kurek J, Zaciera M, Knysak J, et al. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant benzaldehyde. Thorax. 2016;71(4):376-7. https://doi.org/10.1136/ thoraxjnl-2015-207895

  26. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control. 2014;23:77-8. https://doi.org/10.1136/ tobaccocontrol-2012-050604

  27. Moheimani RS, Bhetraratana M, Yin F, Peters KM, Gornbein J, Araujo JA, Middlekauff HR. Increased cardial sympathetic activity and oxidative stress in habitual electronic cigarette users. JAMA Cardiol. 2017;2(3):278-84. https://doi.org/10.1001/jamacardio.2016.5303

  28. Schaal C, Chellappan SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014;12(1):14-23. https://doi.org/10.1158/1541-7786.MCR-13-0541

  29. Davies CD, Ismail A. Nicotine has deleterious effects on wound healing through increased vasoconstriction. BMJ. 2016;353:i2709. https://doi. org/10.1136/bmj.i2709

  30. Beard E, West R, Michie S, Brown J. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy and use of stop smoking services in England: time series analysis of population trends. BMJ. 2016;354:i4645 https://doi.org/10.1136/bmj.i4645

  31. Mayor S. E-cigarettes may be reversing fall in teenage smoking, study finds. BMJ. 2016;354:i3838. https://doi.org/10.1136/bmj.i3838

  32. Kandel ER, Kandel DB. A molecular basis for nicotine as a gateway drug. N Engl J Med. 2014;371:2038-9. https://doi.org/10.1056/NEJMc1411785

  33. Audrain-McGovern J, Stone MD, Barrington-Trimis J, Unger JB, Leventhal AM. Adolescent e-cigarette, hookah and conventional cigarette use and subsequent marijuana use. Pediatrics. 2018;142(3)e20173616. https:// doi.org/10.1542/peds.2017-3616

  34. Organización Mundial de la Salud. Convenio Marco de la OMS para el Control del Tabaco. Ginebra: OMS, 2003. Disponible en: https://www.who. int/tobacco/framework/WHO_fctc_spanish.pdf




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2019;61